Fundraising Fox

LinusBio

Founded 2020 · 31 employees on LinkedIn · 3 known investors

LinusBio is a precision medicine platform company that uses temporal exposomic sequencing of hair to identify molecular biomarkers for earlier diagnosis, patient monitoring, and drug development. Its diagnostic aid ClearStrand-ASD detects a biomarker associated with autism spectrum disorder, and its pipeline targets other central nervous system disorders such as ALS, ADHD, and schizophrenia.

AI & Machine LearningBiotechDigital Health

Investors · 3

Bow CapitalMenlo Park
GreatPoint VenturesSan Francisco · $250K – $20M
Divergent InvestmentsreportedSan Carlos

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

LinusBio is using strands of hair to revolutionize the autism-detection process. Check out the slideshow it used to raise $16 million from GreatPoint and Bow Capital.businessinsider.com · Apr 2023Mount Sinai Spinoff Startup LinusBio Raises $16 Million in Series A funding - Institute for Exposomic Researchmountsinaiexposomics.org · Mar 2023LinusBio Raises $16M for Novel Diagnostics Platform that Can Help Diagnose Autism Early | Clinical Lab Productsclpmag.com · Jan 2023LinusBio Raises $16M in Series A Fundingfinsmes.com · Jan 2023LinusBio Raises $16 Million to Scale Growth and Deliver Tangible Outcomes | AP Newsapnews.com · Jan 2023LinusBio collects $16M with plan to help diagnose autism using a single strand of hairfiercebiotech.com · Jan 2023

Frequently asked questions

What does LinusBio do?
LinusBio is a precision medicine platform company that uses temporal exposomic sequencing of hair to identify molecular biomarkers for earlier diagnosis, patient monitoring, and drug development. Its diagnostic aid ClearStrand-ASD detects a biomarker associated with autism spectrum disorder, and its pipeline targets other central nervous system disorders such as ALS, ADHD, and schizophrenia.
Who are LinusBio's investors?
LinusBio's investors include Bow Capital, GreatPoint Ventures, Divergent Investments.